首页> 外文会议>International Society for Forensic Genetics >Mutation analysis in fatal pulmonarythromboembolism-postmortem validationstudy and beyond
【24h】

Mutation analysis in fatal pulmonarythromboembolism-postmortem validationstudy and beyond

机译:致命肺肺栓塞的突变分析 - 后期验证验证术及超越

获取原文

摘要

Sudden fatal pulmonaiy thromboembolism (PE) is vety common in Caucasians and results in over -120,000 deaths per year. There are both acquired and inherited risk factors for PE The three most common mutations are Factor V Leiden G1691, Prothrombin G20210,And MTHFR C677T. We have developed an in-house molecular testing methodology using polymerase chain reaction (PCR) and automated DNA sequencing technologies The method was validated on postmortem tissue samples, such as heart, spleen, and liver Tissues were stored in RNAlater solution for up to 2 years. The method has also been validated on blood specimens, which were dried on staincards and stored at room temperature for up to 2 years. We obtained results for all tested specimens, including those displaying varying degrees of decomposition. The analytic sensitivity, specificity, and reproducibility show that the method is highly sensitive, and very specific for all three mutations.
机译:突发的致命肺栓塞血栓栓塞(PE)在高加索人中常见,每年有超过10万人死亡。 PE均有获得和遗传的危险因素,三种最常见的突变是因子V leiden G1691,凝血酶原G20210和MTHFR C677T。我们使用聚合酶链反应(PCR)和自动化DNA测序技术开发了内部分子测试方法,并在后模组组织样品上验证了该方法,例如心脏,脾和肝组织储存在大约2年中。该方法还曾在血液标本上验证,将其在印度卡上干燥并在室温下储存长达2年。我们获得了所有测试标本的结果,包括显示不同程度的分解的结果。分析敏感性,特异性和再现性表明该方法对所有三个突变具有非常敏感的,并且非常具体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号